246 related articles for article (PubMed ID: 9770421)
1. Retrograde transport of intact poliovirus through the axon via the fast transport system.
Ohka S; Yang WX; Terada E; Iwasaki K; Nomoto A
Virology; 1998 Oct; 250(1):67-75. PubMed ID: 9770421
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis of poliovirus neurovirulence.
Ohka S; Nomoto A
Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
[TBL] [Abstract][Full Text] [Related]
3. Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome.
Ohka S; Matsuda N; Tohyama K; Oda T; Morikawa M; Kuge S; Nomoto A
J Virol; 2004 Jul; 78(13):7186-98. PubMed ID: 15194795
[TBL] [Abstract][Full Text] [Related]
4. Multiple pathways for establishment of poliovirus infection.
Arita M; Ohka S; Sasaki Y; Nomoto A
Virus Res; 1999 Aug; 62(2):97-105. PubMed ID: 10507320
[TBL] [Abstract][Full Text] [Related]
5. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
Yang WX; Terasaki T; Shiroki K; Ohka S; Aoki J; Tanabe S; Nomura T; Terada E; Sugiyama Y; Nomoto A
Virology; 1997 Mar; 229(2):421-8. PubMed ID: 9126254
[TBL] [Abstract][Full Text] [Related]
6. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
7. Poliovirus-sensitive transgenic mice as a new animal model.
Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
[TBL] [Abstract][Full Text] [Related]
8. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
[TBL] [Abstract][Full Text] [Related]
9. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response.
Lancaster KZ; Pfeiffer JK
PLoS Pathog; 2010 Mar; 6(3):e1000791. PubMed ID: 20221252
[TBL] [Abstract][Full Text] [Related]
10. [The observation on infection of trasgenic mice (PVR Tg21) with polioviruses type 3].
Guo R; Chen S; Luo Q; Wang Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):70-5. PubMed ID: 11367738
[TBL] [Abstract][Full Text] [Related]
11. Gene expression in the muscle and central nervous system following intramuscular inoculation of encapsidated or naked poliovirus replicons.
Jackson CA; Messinger J; Palmer MT; Peduzzi JD; Morrow CD
Virology; 2003 Sep; 314(1):45-61. PubMed ID: 14517059
[TBL] [Abstract][Full Text] [Related]
12. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.
Dragunsky E; Taffs R; Chernokhvostova Y; Nomura T; Hioki K; Gardner D; Norwood L; Levenbook I
Biologicals; 1996 Jun; 24(2):77-86. PubMed ID: 8889053
[TBL] [Abstract][Full Text] [Related]
13. Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons.
Ohka S; Sakai M; Bohnert S; Igarashi H; Deinhardt K; Schiavo G; Nomoto A
J Virol; 2009 May; 83(10):4995-5004. PubMed ID: 19244317
[TBL] [Abstract][Full Text] [Related]
14. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
[TBL] [Abstract][Full Text] [Related]
15. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
Racaniello VR; Ren R; Bouchard M
Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
[TBL] [Abstract][Full Text] [Related]
16. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice.
Deatly AM; Coleman JW; McMullen G; McAuliffe JM; Jayarama V; Cupo A; Crowley JC; McWilliams T; Taffs RE
Virology; 1999 Mar; 255(2):221-7. PubMed ID: 10069947
[TBL] [Abstract][Full Text] [Related]
17. [Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses].
Dai C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):34-8. PubMed ID: 7686824
[TBL] [Abstract][Full Text] [Related]
18. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
19. Comparison of neuropathogenicity of poliovirus in two transgenic mouse strains expressing human poliovirus receptor with different distribution patterns.
Ida-Hosonuma M; Iwasaki T; Taya C; Sato Y; Li J; Nagata N; Yonekawa H; Koike S
J Gen Virol; 2002 May; 83(Pt 5):1095-1105. PubMed ID: 11961264
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mouse lines transgenic with the human poliovirus receptor gene.
Deatly AM; Taffs RE; McAuliffe JM; Nawoschik SP; Coleman JW; McMullen G; Weeks-Levy C; Johnson AJ; Racaniello VR
Microb Pathog; 1998 Jul; 25(1):43-54. PubMed ID: 9705248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
